Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: Possible pharmacokinetic effects

Psychopharmacology

Volumn 174, Issue 3, 2004, Pages 406-413

  Fletcher, Paul J ^a,b   Sinyard, Judy ^b   Salsali, Mahnaz ^c   Baker, Glen B ^c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

5,7 Dihydroxytryptamine; Cytochrome p450; Pharmacokinetic interaction; Serotonin (5 HT); SSSRI

Indexed keywords

5,7 DIHYDROXYTRYPTAMINE; CITALOPRAM; COCAINE; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG POTENTIATION; HABITUATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOCOMOTION; MALE; MEDIAN RAPHE NUCLEUS; MONITOR; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; ULTRAVIOLET RADIATION;

EID: 3843058001     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1747-9     Document Type: Article

References (48)

1. Andrews CM, Lucki I (2001) Effects of cocaine on extracellular dopamine and serotonin levels in the nucleus accumbens. Psychopharmacology 155:221-229
2. Auerbach SB, Wilkinson LO, Rui T, Grauer S, Rutter J (1992) Microdialysis measurement of serotonin release in the central nervous system. J Chem Neuroanat 5:331-333
3. Baker LE, Riddle EE, Saunders RB, Appel JB (1993) The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds. Behav Pharmacol 4:69-79
4. Brosen K, Naranjo CA (2001) Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram. Eur Neuropsychopharmacol 11:275-283
5. Bubar MJ, McMahon LR, De Deurwaerdere P, Spampinato U, Cunningham KA (2003) Selective serotonin reuptake inhibitors enhance cocaine-induced locomotor activity and dopamine release in the nucleus accumbens. Neuropharmacology 44:342-353
6. Bymaster FP, Zhang W, Carter PA, Shaw J, Chernet E, Phebus L, Wong DT, Perry KW (2002) Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology 160:353-361
7. 1B receptor agonists. Neuropharmacology 36:373-381
8. 2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine. Psychopharmacology 103:50-55
9. Cunningham KA, Callahan PM (1991) Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology 104:177-180
10. De La Garza R 2nd, Cunningham KA (2000) The effects of the 5-hydroxytryptamine(1A) agonist 8-hydroxy-2-(di-n-propylamino)tetralin on spontaneous activity, cocaine-induced hyperactivity and behavioral sensitization: a microanalysis of locomotor activity. J Pharmacol Exp Ther 292:610-617
11. Fletcher PJ (1995) Effects of d-fenfluramine and metergoline on responding for conditioned reward and the response potentiating effect of nucleus accumbens d-amphetamine. Psychopharmacology 118:155-163
12. Fletcher PJ, Korth KM, Chambers JW (1999) Selective destruction of brain serotonin neurons by 5,7-dihydroxytryptamine increases responding for a conditioned reward. Psychopharmacology 147:291-299
13. 2C receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacology 27:576-586
14. Gardier AM, Lepoul E, Trouvin JH, Chanut E, Dessalles MC, Jacquot C (1994) Changes in dopamine metabolism in rat forebrain regions after cessation of long-term fluoxetine treatment: relationship with brain concentrations of fluoxetine and norfluoxetine. Life Sci 54:PL51-56
15. Gobbi M, Regondi MC, Pompeiano M, Palacios JM, Mennini T (1994) Differential effects of 5,7-dihydroxytryptamine-induced serotoninergic degeneration of 5-HT1A receptors and 5-HT uptake sites in the rat brain. J Chem Neuroanat 7:65-73
16. 2C receptors on cocaine- and food-maintained behavior. J Pharmacol Exp Ther 295:1183-1191
17. Hemeryck A, Belpaire FM (2002) Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update. Curr Drug Metab 3:13-37
18. Herges S, Taylor DA (1998) Involvement of serotonin in the modulation of cocaine-induced locomotor activity in the rat. Pharmacol Biochem Behav 59:595-611
19. Inaba T (1989) Cocaine: pharmacokinetics and biotransformation in man. Can J Physiol Pharmacol 67:1154-1157
20. Iribarne C, Picart D, Dreano Y, Berthou F (1998) In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine. Fundam Clin Pharmacol 12:194-199
21. Kelly PH, Iversen SD (1976) Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol 40:45-56
22. Kleven MS, Koek W (1998) Discriminative stimulus properties of cocaine: enhancement by monoamine reuptake blockers. J Pharmacol Exp Ther 284:1015-1025
23. Koch S, Perry KW, Nelson DL, Conway RG, Threlkeld PG, Bymaster FP (2002) R-Fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study. Neuropsychopharmacology 27:949-959
24. Li SX, Perry KW, Wong DT (2002) Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats. Neuropharmacology 42:181-190
25. 2C/2B antagonist SB 206553 on hyperactivity induced by cocaine. Neuropsychopharmacology 20:556-564
26. 2a receptors attenuates the behavioral effects of cocaine in rats. J Pharmacol Exp Ther 297:357-363
27. 2C receptors: a comparison with citalopram. Eur J Neurosci 12:1079-1095
28. Morrow BA, Roth RH (1996) Serotonergic lesions alter cocaine-induced locomotor behavior and stress-activation of the mesocorticolimbic dopamine system. Synapse 23:174-181
29. 1A-receptor antagonist WAY 100635 blocks behavioral stimulating effects of cocaine but not ventral striatal dopamine increase. Behav Brain Res 134:337-346
30. Muller CP, Carey RJ, Salloum JB, Huston JP (2003) Serotonin1A-receptor agonism attenuates the cocaine-induced increase in serotonin levels in the hippocampus and nucleus accumbens but potentiates hyperlocomotion: an in vivo microdialysis study. Neuropharmacology 44:592-603
31. Pai HV, Upadhya SC, Chinta SJ, Hegde SN, Ravindranath V (2002) Differential metabolism of alprazolam by liver and brain cytochrome (P4503A) to pharmacologically active metabolite. Pharmacogenomics J 2:243-258
32. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, New York
33. Pellinen P, Honkakoski P, Stenback F, Niemitz M, Alhava E, Pelkonen O, Lang MA, Pasanen M (1994) Cocaine N-demethylation and the metabolism-related hepatotoxicity can be prevented by cytochrome P450 3A inhibitors. Eur J Pharmacol 270:35-43
34. Pellinen P, Kulmala L, Konttila J, Auriola S, Pasanen M, Juvonen R (2000) Kinetic characteristics of norcocaine N-hydroxylation in mouse and human liver microsomes: involvement of CYP enzymes. Arch Toxicol 74:511-520
35. Poet TS, McQueen CA, Halpert JR (1996) Participation of cytochromes P4502B and P4503A in cocaine toxicity in rat hepatocytes. Drug Metab Dispos 24:74-80
36. Reith ME, Wiener HL, Fischette CT (1991) Sertraline and cocaine-induced locomotion in mice. I. Acute studies. Psychopharmacology 103:297-305
37. Ritz MC, Kuhar MJ (1989) Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine. J Pharmacol Exp Ther 248:1010-1017
38. Roberts DC, Koob GF, Klonoff P, Fibiger HC (1980) Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol Biochem Behav 12:781-787
39. Rutter JJ, Gundlah C, Auerbach SB (1994) Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine. Neurosci Lett 171:183-186
40. Sasaki-Adams DM, Kelley AE (2001) Serotonin-dopamine interactions in the control of conditioned reinforcement and motor behavior. Neuropsychopharmacology 25:440-452
41. Scheffel U, Ricaurte GA (1990) Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamine neurotoxicity: a presynaptic serotonergic positron emission tomography ligand? Brain Res 527:89-95
42. Sills TL, Greenshaw AJ, Baker GB, Fletcher PJ (1999a) Acute fluoxetine treatment potentiates amphetamine hyperactivity and amphetamine-induced nucleus accumbens dopamine release: possible pharmacokinetic interaction. Psychopharmacology 141:421-427
43. Sills TL, Greenshaw AJ, Baker GB, Fletcher PJ (1999b) The potentiating effect of sertraline and fluoxetine on amphetamine-induced locomotor activity is not mediated by serotonin. Psychopharmacology 143:426-432
44. Spealman RD (1993) Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys. Psychopharmacology 112:93-99
45. Sprouse J, Clarke T, Reynolds L, Heym J, Rollema H (1996) Comparison of the effects of sertraline and its metabolite desmethylsertraline on blockade of central 5-HT reuptake in vivo. Neuropsychopharmacology 14:225-231
46. Tella SR, Goldberg SR (1993) Monoamine uptake inhibitors alter cocaine pharmacokinetics. Psychopharmacology 112:497-502
47. Teneud LM, Baptista T, Murzi E, Hoebel BG, Hernandez L (1996) Systemic and local cocaine increase extracellular serotonin in the nucleus accumbens. Pharmacol Biochem Behav 53:747-752
48. von Moltke LL, Greenblatt DJ, Cotreau-Bibbo MM, Harmatz JS, Shader RI (1994) Inhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidine. Br J Clin Pharmacol 38:23-31